SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales surged to Rs. 3024.05 millions, up 25.85% for the December 2022 quarter as against Rs. 2402.97 millions during the corresponding quarter previous year.Net profit surges 96.46% to Rs. 292.20  millions  from Rs. 148.73 millions in the quarter ended December 2022.Operating Profit saw a handsome growth to 642.69 millions from 615.55 millions in the quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 3024.05 2402.97 25.85 8614.75 7122.71 20.95 9880.90 8565.78 15.35
Other Income 83.58 79.87 4.65 232.93 217.04 7.32 417.16 231.28 80.37
PBIDT 642.69 615.55 4.41 1890.43 1804.89 4.74 2361.90 2036.24 15.99
Interest 223.83 237.29 -5.67 703.44 720.50 -2.37 955.33 1002.16 -4.67
PBDT 418.86 361.34 15.92 1186.99 1067.47 11.20 1389.65 1034.08 34.39
Depreciation 154.25 212.61 -27.45 480.78 491.92 -2.26 1309.70 872.92 50.04
PBT 264.61 148.73 77.91 706.21 575.55 22.70 79.95 161.16 -50.39
TAX -27.59 0.00 0.00 -27.59 0.78 -3637.18 137.05 205.16 -33.20
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -109.17 94.76 -215.21
PAT 292.20 148.73 96.46 733.80 574.77 27.67 -57.10 -44.00 29.77
Equity 590.87 590.87 0.00 590.87 590.87 0.00 590.87 590.87 0.00
PBIDTM(%) 21.25 25.62 -17.03 21.94 25.34 -13.40 23.90 23.77 0.55

Ind-Swift Lab. Share Price

132.00 -13.30 (-9.15%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×